SCD and cancer: The colorectalcancer cells with irinotecan resistance43 possess elevated unsaturated lipids and cancer stem cell markers,pointing to the upregulation of SCD1 as a key factor in resistance.These findings suggested that inhibiting SCD1 could enhance irinotecansensitivity, offering a potential approach to overcoming drug resistancein clinical treatment.